PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The hallucinogenic drug is an option when traditional treatment isn’t ...

In the wake of the tragic death of cult British singer Danielle Moore, who took her own life after experiencing severe mental ...

Depression impacts an estimated 18 million Americans each year, yet depression screening rarely occurs in the outpatient ...

Machine learning analysis of voice recordings shows promise for detecting depression, with over 70% accuracy, improving ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

“Major depression is one of the greatest health ... “The longer we can keep patients from having severe symptoms from reoccurring improves their overall prognosis over the course of their ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...

A study appearing in The Annals of Family Medicine evaluated an AI-based machine learning biomarker tool that uses speech patterns to detect moderate to severe depression, aiming to improve access ...

Spravato, a newly FDA-approved nasal spray, offers hope for individuals with treatment-resistant depression, a condition ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.